The government must support a patent waiver for COVID-19 vaccines and treatments to protect the UK’s own vaccination program, according to public health experts from the Independent SAGE group.
With more virulent strains spreading across the world while billions of people go unvaccinated, the risk of variants resistant to current vaccines emerges, so Independent SAGE wants the UK government to support a waiver of the global agreement on trade-related aspects of intellectual property (TRIPS) at the World Trade Organization.
"The US government is reconsidering its opposition – and so must the UK"This has been proposed by India and South Africa and supported by more than 100 countries, but the UK is one of a small number of nations blocking the move.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze